Literature DB >> 27265406

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.

Adam H Buchanan1, Corrine I Voils2,3, Joellen M Schildkraut4, Catherine Fine5, Nora K Horick6, P Kelly Marcom3,4, Kristi Wiggins7, Celette Sugg Skinner8.   

Abstract

Identifying unaffected women with a BRCA mutation can have a significant individual and population health impact on morbidity and mortality if these women adhere to guidelines for managing cancer risk. But, little is known about whether such women are adherent to current guidelines. We conducted telephone surveys of 97 unaffected BRCA mutation carriers who had genetic counseling at least one year prior to the survey to assess adherence to current guidelines, factors associated with adherence, and common reasons for performing and not performing recommended risk management. More than half of participants reported being adherent with current risk management recommendations for breast cancer (69 %, n = 67), ovarian cancer (82 %, n = 74) and both cancers (66 %, n = 64). Older age (OR = 10.53, p = 0.001), white race (OR = 8.93, p = 0.019), higher breast cancer genetics knowledge (OR = 1.67, p = 0.030), higher cancer-specific distress (OR = 1.07, p = 0.002) and higher physical functioning (OR = 1.09, p = 0.009) were significantly associated with adherence to recommended risk management for both cancers. Responses to open-ended questions about reasons for performing and not performing risk management behaviors indicated that participants recognized the clinical utility of these behaviors. Younger individuals and those with lower physical functioning may require targeted interventions to improve adherence, perhaps in the setting of long-term follow-up at a multi-disciplinary hereditary cancer clinic.

Entities:  

Keywords:  BRCA1 gene; BRCA2 gene; Breast cancer; Genetic counseling; Ovarian cancer

Mesh:

Year:  2016        PMID: 27265406      PMCID: PMC5140768          DOI: 10.1007/s10897-016-9981-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  59 in total

1.  Validity of women's self-reports of cancer screening test utilization in a managed care population.

Authors:  Lee S Caplan; David V McQueen; Judith R Qualters; Marilyn Leff; Carol Garrett; Ned Calonge
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

2.  How valid are mammography self-reports?

Authors:  E S King; B K Rimer; B Trock; A Balshem; P Engstrom
Journal:  Am J Public Health       Date:  1990-11       Impact factor: 9.308

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

Authors:  Jeffrey R Botkin; Ken R Smith; Robert T Croyle; Bonnie J Baty; Jean E Wylie; Debra Dutson; Anna Chan; Heidi A Hamann; Caryn Lerman; Jamie McDonald; Vickie Venne; John H Ward; Elaine Lyon
Journal:  Am J Med Genet A       Date:  2003-04-30       Impact factor: 2.802

5.  Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.

Authors:  Ellen Warner; Kimberley Hill; Petrina Causer; Donald Plewes; Roberta Jong; Martin Yaffe; William D Foulkes; Parviz Ghadirian; Henry Lynch; Fergus Couch; John Wong; Frances Wright; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

6.  Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer.

Authors:  Erna Claes; Gerry Evers-Kiebooms; Marleen Decruyenaere; Lieve Denayer; Andrea Boogaerts; Kristien Philippe; Eric Legius
Journal:  Behav Med       Date:  2005       Impact factor: 3.104

7.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Authors:  C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch
Journal:  Prev Med       Date:  2000-07       Impact factor: 4.018

8.  Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Authors:  Anne Uyei; Susan K Peterson; Julie Erlichman; Kristine Broglio; Sandra Yekell; Kathkeen Schmeler; Karen Lu; Funda Meric-Bernstam; Chris Amos; Louise Strong; Banu Arun
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

9.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

10.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus Couch; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

View more
  8 in total

Review 1.  Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants.

Authors:  Melissa Walker; Michelle Jacobson; Mara Sobel
Journal:  CMAJ       Date:  2019-08-12       Impact factor: 8.262

2.  Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.

Authors:  Deborah Cragun; Anne Weidner; Courtney Lewis; Devon Bonner; Jongphil Kim; Susan T Vadaparampil; Tuya Pal
Journal:  Cancer       Date:  2017-02-09       Impact factor: 6.860

3.  An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data.

Authors:  Stephanie A Cohen; Courtney Lynam Scherr; Dawn M Nixon
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

4.  Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.

Authors:  Eliza Courtney; Xin Wei Chin; Jeanette Yuen; Shao-Tzu Li; Yanni Chen; John Carson Allen; Veronique Tan; Geok Hoon Lim; Joanne Ngeow
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

5.  Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

Authors:  Stephanie Kearton; Karen Wills; Michael Bunting; Penny Blomfield; Paul A James; Jo Burke
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

Review 6.  Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.

Authors:  Kathleen F Mittendorf; Sarah Knerr; Tia L Kauffman; Nangel M Lindberg; Katherine P Anderson; Heather Spencer Feigelson; Marian J Gilmore; Jessica Ezzell Hunter; Galen Joseph; Stephanie A Kraft; Jamilyn M Zepp; Sapna Syngal; Benjamin S Wilfond; Katrina A B Goddard
Journal:  JCO Precis Oncol       Date:  2021-11-03

7.  Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants.

Authors:  Adam H Buchanan; Kandamurugu Manickam; Michelle N Meyer; Jennifer K Wagner; Miranda L G Hallquist; Janet L Williams; Alanna Kulchak Rahm; Marc S Williams; Zong-Ming E Chen; Chaitali K Shah; Tullika K Garg; Amanda L Lazzeri; Marci L B Schwartz; D'Andra M Lindbuchler; Audrey L Fan; Rosemary Leeming; Pedro O Servano; Ashlee L Smith; Victor G Vogel; Noura S Abul-Husn; Frederick E Dewey; Matthew S Lebo; Heather M Mason-Suares; Marylyn D Ritchie; F Daniel Davis; David J Carey; David T Feinberg; W Andrew Faucett; David H Ledbetter; Michael F Murray
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

8.  Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents.

Authors:  Juliann M Savatt; Jennifer K Wagner; Steven Joffe; Alanna Kulchak Rahm; Marc S Williams; Angela R Bradbury; F Daniel Davis; Julie Hergenrather; Yirui Hu; Melissa A Kelly; H Lester Kirchner; Michelle N Meyer; Jessica Mozersky; Sean M O'Dell; Josie Pervola; Andrea Seeley; Amy C Sturm; Adam H Buchanan
Journal:  BMC Pediatr       Date:  2020-05-15       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.